These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advancements in the management of pancreatic cancer: 2013. Saif MW JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549 [TBL] [Abstract][Full Text] [Related]
4. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Christenson ES; Jaffee E; Azad NS Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117 [TBL] [Abstract][Full Text] [Related]
5. Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials. Kaur J; Singh P; Enzler T; Sahai V Expert Opin Emerg Drugs; 2021 Jun; 26(2):103-129. PubMed ID: 33734833 [No Abstract] [Full Text] [Related]
6. Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease. Tsai S; Christians KK; Ritch PS; George B; Khan AH; Erickson B; Evans DB J Oncol Pract; 2016 Oct; 12(10):915-923. PubMed ID: 27858562 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic adenocarcinoma: Beyond first line, where are we? Cherri S; Noventa S; Zaniboni A World J Gastroenterol; 2021 May; 27(17):1847-1863. PubMed ID: 34007126 [TBL] [Abstract][Full Text] [Related]
8. Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review. Gostimir M; Bennett S; Moyana T; Sekhon H; Martel G BMC Cancer; 2016 Oct; 16(1):786. PubMed ID: 27724927 [TBL] [Abstract][Full Text] [Related]
13. Current progress in immunotherapy for pancreatic cancer. Foley K; Kim V; Jaffee E; Zheng L Cancer Lett; 2016 Oct; 381(1):244-51. PubMed ID: 26723878 [TBL] [Abstract][Full Text] [Related]
14. Update on the management of pancreatic cancer: surgery is not enough. Ansari D; Gustafsson A; Andersson R World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920 [TBL] [Abstract][Full Text] [Related]
15. Current standards and new innovative approaches for treatment of pancreatic cancer. Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines. Okusaka T; Furuse J J Gastroenterol; 2020 Apr; 55(4):369-382. PubMed ID: 31997007 [TBL] [Abstract][Full Text] [Related]
18. Drug development and clinical trial design in pancreatico-biliary malignancies. Harrington J; Carter L; Basu B; Cook N Curr Probl Cancer; 2018; 42(1):73-94. PubMed ID: 29402439 [TBL] [Abstract][Full Text] [Related]
19. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment. Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501 [TBL] [Abstract][Full Text] [Related]